Hiroki Inada

Kumamoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomized Trial of Rifaximin for Covert Hepatic Encephalopathy. Authors' Reply.

Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomized Trial of Rifaximin for Covert Hepatic Encephalopathy. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: July 07, 2026

Editorial: Rifaximin and the Gut-Liver-Brain Axis-Progress and Prudence. Authors' Reply.

Editorial: Rifaximin and the Gut-Liver-Brain Axis-Progress and Prudence. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: June 20, 2026

Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab.

Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 19, 2026

Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial.

Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial.

Journal: Alimentary pharmacology & therapeutics

Published: January 25, 2026

Mendelian Randomization Using a Japanese GWAS Identifies an HLA-Linked Causal Effect of Chronic Hepatitis B on Cholangiocarcinoma Risk.

Mendelian Randomization Using a Japanese GWAS Identifies an HLA-Linked Causal Effect of Chronic Hepatitis B on Cholangiocarcinoma Risk.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: December 02, 2025

Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational Study.

Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 20, 2025

TP53 mutation predicts resistance to immune checkpoint inhibitor-based therapy in intrahepatic cholangiocarcinoma.

TP53 mutation predicts resistance to immune checkpoint inhibitor-based therapy in intrahepatic cholangiocarcinoma.

Journal: Journal of gastroenterology

Published: July 28, 2025

Activation of canonical Wnt signaling is required for efficient direct reprogramming into human hepatic progenitor cells.

Activation of canonical Wnt signaling is required for efficient direct reprogramming into human hepatic progenitor cells.

Journal: Stem cell reports

Published: January 16, 2025

Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.

Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.

Journal: Journal of gastroenterology

Published: January 14, 2025

Neutrophil-to-lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

Neutrophil-to-lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: January 07, 2025

Serum alpha-fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis.

Serum alpha-fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 23, 2024

Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer.

Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer.

Journal: International journal of clinical oncology

Published: July 07, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026